Cystic fibrosis transmembrane conductance regulator (CFTR) gene mutations in Asians with chronic pulmonary disease: A pilot study

Journal of Cystic Fibrosis

Volumn 5, Issue 3, 2006, Pages 159-164

  Ngiam, Nicola S P ^a,b   Chong, Samuel S ^a   Shek, Lynette P C ^a,b   Goh, Denise L M ^a,b   Ong, K C ^c   Chng, S Y ^b   Yeo, G H ^a   Goh, Daniel Y T ^a,b  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b NATIONAL UNIVERSITY HOSPITAL   (Singapore)

^c MOUNT ELIZABETH MEDICAL CENTRE   (Singapore)

Author keywords

Asians; Asthma; Bronchiectasis; CFTR mutations

Indexed keywords

GLUTAMINE; HISTIDINE; ISOLEUCINE; THREONINE; TRANSMEMBRANE CONDUCTANCE REGULATOR; VALINE;

ADULT; AGED; ARTICLE; ASIAN; ASTHMA; BRONCHIECTASIS; CHINESE; CHRONIC DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CYSTIC FIBROSIS; DISEASE PREDISPOSITION; DISEASE SEVERITY; EXON; FEMALE; GENE FREQUENCY; GENE MUTATION; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC SCREENING; GENETIC VARIABILITY; HUMAN; INTRON; LUNG DISEASE; MALE; MISSENSE MUTATION; PILOT STUDY; SINGAPORE;

ADULT; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; ASTHMA; BRONCHIECTASIS; CASE-CONTROL STUDIES; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; GENETIC TESTING; HUMANS; MALE; MIDDLE AGED; MUTATION, MISSENSE; POLYMORPHISM, GENETIC; RISK FACTORS;

EID: 33746196738     PISSN: 15691993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcf.2006.02.002     Document Type: Article

References (29)

1. Wong L.J., Wang J., Zhang Y.H., et al. Improved detection of CFTR mutations in Southern California Hispanic CF patients. Hum Mutat 18 (2001) 296-307
2. Bobadilla J.L., Macek Jr. M., Fine J.P., and Farrell P.M. Cystic fibrosis: a worldwide analysis of CFTR mutations-correlation with incidence data and application to screening. Hum Mutat 19 (2002) 575-606
3. Casals T., Ramos M.D., Gimenez J., Larriba S., Nunes V., and Estivill X. High heterogeneity for cystic fibrosis in Spanish families: 75 mutations account for 90% of chromosomes. Hum Genet 101 (1997) 365-370
4. Mennie M., Gilfillan A., Brock D.J., and Liston W.A. Heterozygotes for the delta F508 cystic fibrosis allele are not protected against bronchial asthma. Nat Med 1 (1995) 978-979
5. Dahl M., Tybjaerg-Hansen A., Lange P., and Nordestgaard B.G. DeltaF508 heterozygosity in cystic fibrosis and susceptibility to asthma. Lancet 351 (1998) 1911-1913
6. Schroeder S.A., Gaughan D.M., and Swift M. Protection against bronchial asthma by CFTR delta F508 mutation: a heterozygote advantage in cystic fibrosis. Nat Med 1 (1995) 703-705
7. Pignatti P.F., Bombieri C., Marigo C., Benetazzo M., and Luisetti M. Increased incidence of cystic fibrosis gene mutations in adults with disseminated bronchiectasis. Hum Mol Genet 4 (1995) 635-639
8. Tzetis M., Efthymiadou A., Strofalis S., et al. CFTR gene mutations - including three novel nucleotide substitutions - and haplotype background in patients with asthma, disseminated bronchiectasis and chronic obstructive pulmonary disease. Hum Genet 108 (2001) 216-221
9. Girodon E., Cazeneuve C., Lebargy F., et al. CFTR gene mutations in adults with disseminated bronchiectasis. Eur J Hum Genet 5 (1997) 149-155
10. Bombieri C., Benetazzo M., Saccomani A., et al. Complete mutational screening of the CFTR gene in 120 patients with pulmonary disease. Hum Genet 103 (1998) 718-722
11. Casals T., De-Gracia J., Gallego M., et al. Bronchiectasis in adult patients: an expression of heterozygosity for CFTR gene mutations?. Clin Genet 65 (2004) 490-495
12. King P.T., Freezer N.J., Holmes P.W., Holdsworth S.R., Forshaw K., and Sart D.D. Role of CFTR mutations in adult bronchiectasis. Thorax 59 (2004) 357-358
13. Divac A., Nikolic A., Mitic-Milikic M., et al. CFTR mutations and polymorphisms in adults with disseminated bronchiectasis: a controversial issue. Thorax 60 (2005) 85
14. Marchand E., Verellen-Dumoulin C., Mairesse M., et al. Frequency of cystic fibrosis transmembrane conductance regulator gene mutations and 5T allele in patients with allergic bronchopulmonary aspergillosis. Chest 119 (2001) 762-767
15. Zielenski J., Markiewicz D., Lin S.P., Huang F.Y., Yang-Feng T.L., and Tsui L.C. Skipping of exon 12 as a consequence of a point mutation (1898 + 5G→T) in the cystic fibrosis transmembrane conductance regulator gene found in a consanguineous Chinese family. Clin Genet 47 (1995) 125-132
16. Wagner J.A., Vassilakis A., Yee K., et al. Two novel mutations in a cystic fibrosis patient of Chinese origin. Hum Genet 104 (1999) 511-515
17. Wu C.L., Shu S.G., Zielenski J., Chiang C.D., and Tsui L.C. Novel cystic fibrosis mutation (2215insG) in two adolescent Taiwanese siblings. J Formos Med Assoc 99 (2000) 564-567
18. Anzai C., Morokawa N., Okada H., Kamidono S., Eto Y., and Yoshimura K. CFTR gene mutations in Japanese individuals with congenital bilateral absence of the vas deferens. J Cyst Fibros 2 (2003) 14-18
19. Wu C.C., Alper O.M., Lu J.F., et al. Mutation spectrum of the CFTR gene in Taiwanese patients with congenital bilateral absence of the vas deferens. Hum Reprod 20 (2005) 2470-2475
20. Wong L.J., Alper O.M., Wang B.T., Lee M.H., and Lo S.Y. Two novel null mutations in a Taiwanese cystic fibrosis patient and a survey of East Asian CFTR mutations. Am J Med Genet A 120 (2003) 296-298
21. Cystic Fibrosis Genetic Analysis Consortium. Cystic Fibrosis Mutation Database. www.genet.sickkids.on.ca/cftr/. Date last updated: 26 September 2005. Date last accessed: 28 September 2005.
22. Lee J.H., Choi J.H., Namkung W., et al. A haplotype-based molecular analysis of CFTR mutations associated with respiratory and pancreatic diseases. Hum Mol Genet 12 (2003) 2321-2332
23. Lee K.H., Ryu J.K., Yoon W.J., Lee J.K., Kim Y.T., and Yoon Y.B. Mutation analysis of SPINK1 and CFTR gene in Korean patients with alcoholic chronic pancreatitis. Dig Dis Sci 50 (2005) 1852-1856
24. Ghanem N., Costes B., Girodon E., Martin J., Fanen P., and Goossens M. Identification of eight mutations and three sequence variations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene. Genomics 21 (1994) 434-436
25. Cuppens H., Lin W., Jaspers M., et al. Polyvariant mutant cystic fibrosis transmembrane conductance regulator genes. The polymorphic (Tg)m locus explains the partial penetrance of the T5 polymorphism as a disease mutation. J Clin Invest 101 (1998) 487-496
26. Chu C.S., Trapnell B.C., Murtagh Jr. J.J., et al. Variable deletion of exon 9 coding sequences in cystic fibrosis transmembrane conductance regulator gene mRNA transcripts in normal bronchial epithelium. EMBO J 10 (1991) 1355-1363
27. Chu C.S., Trapnell B.C., Curristin S., Cutting G.R., and Crystal R.G. Genetic basis of variable exon 9 skipping in cystic fibrosis transmembrane conductance regulator mRNA. Nat Genet 3 (1993) 151-156
28. Strong T.V., Wilkinson D.J., Mansoura M.K., et al. Expression of an abundant alternatively spliced form of the cystic fibrosis transmembrane conductance regulator (CFTR) gene is not associated with a cAMP-activated chloride conductance. Hum Mol Genet 2 (1993) 225-230
29. Groman J.D., Hefferon T.W., Casals T., et al. Variation in a repeat sequence determines whether a common variant of the cystic fibrosis transmembrane conductance regulator gene is pathogenic or benign. Am J Hum Genet 74 (2004) 176-179